Biospecimens, such as blood, urine and cerebrospinal fluid, collected from ADNI participants are available through ADNI and managed by the Resource Allocation Review Committee (RARC).
Neuropathological tissue is offered by the Alzheimer’s Disease Research Center (ADRC) at Washington University. All requests for the use of ADRC resources (data, tissue, subjects, services) must be approved by the ADRC Executive Committee.
Please Note: Following application approval by the RARC, samples will be provided to investigators with coded identifiers. Under ADNI policy, all results must be submitted to the ADNI representative once analysis and quality control are completed at which time, they will be re-linked and uploaded into the ADNI database where you (and others) may access them.
Use of ADNI samples for technology development or comparisons among different technologies is not recommended for well-established analytes unless there is preliminary data showing clearly superior performance.
More Information about ADNI Samples are available from the 2010 ADNI GO Training Meeting: